Allogeneic hemopoietic stem cell transplantation for patients with myelofibrosis / 中国实用内科杂志
Chinese Journal of Practical Internal Medicine
; (12): 139-142, 2019.
Article
en Zh
| WPRIM
| ID: wpr-815994
Biblioteca responsable:
WPRO
ABSTRACT
Allogeneic hematopoietic stem cell transplantation(allo-HSCT) is the only therapy to cure myelofibrosis(MF) at present. This article gives a review on the following problems: who needs allo-SCT, how to choose allo-SCT in the era of ruxolitinib, the role of Ruxolitinib in the transplantation, whether allo-SCT can cure MF, and how to improve the effect of allo-SCT to guide the allo-SCT, in order for MF patients in clinical work.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Practical Internal Medicine
Año:
2019
Tipo del documento:
Article